 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

---
- 'ANN ARBOR, Mich., Sept. 13, 2021 (GLOBE NEWSWIRE) -- Zomedica Corp. (NYSE American:
  ZOM) (Zomedica or the Company), a veterinary health company creating point-of-care
  diagnostics products for dogs and cats, announced that Sean Whelan has been appointed
  to its Board of Directors to fill the vacancy ...'


Sean Whelan Appointed to Board of Directors

---
- Bank of New York Mellon Corp raised its stake in shares of Diplomat Pharmacy Inc
  (NYSE:DPLO) by 0.8% during the fourth quarter, HoldingsChannel reports. The firm
  owned 655,472 shares of the companys stock after buying an additional 5,158 shares
  during the quarter. Bank of New York Mellon Corp...


Bank of New York Mellon Corp Raises Position in Diplomat Pharmacy Inc (NYSE:DPLO)

---
- Cubist Systematic Strategies LLC cut its holdings in Diplomat Pharmacy Inc (NYSE:DPLO)
  by 16.0% during the 4th quarter, according to its most recent 13F filing with the
  Securities and Exchange Commission. The institutional investor owned 20,338 shares
  of the companys stock after selling 3,865...


Cubist Systematic Strategies LLC Sells 3,865 Shares of Diplomat Pharmacy Inc (NYSE:DPLO)

---
- Jane Street Group LLC purchased a new stake in shares of Diplomat Pharmacy Inc (NYSE:DPLO)
  during the fourth quarter, according to the company in its most recent 13F filing
  with the Securities  Exchange Commission. The firm purchased 23,823 shares of the
  companys stock, valued at ...


Jane Street Group LLC Purchases Shares of 23,823 Diplomat Pharmacy Inc (NYSE:DPLO)

---
- Diplomat Pharmacy Inc (NYSE:DPLO) has received an average recommendation of Hold
  from the nine analysts that are covering the firm, MarketBeat.com reports. Three
  research analysts have rated the stock with a sell rating, five have assigned a
  hold rating and one has given a buy rating ...


Diplomat Pharmacy Inc (NYSE:DPLO) Receives Consensus Rating of "Hold" from Brokerages

---
- Citigroup Inc. cut its position in shares of Diplomat Pharmacy Inc (NYSE:DPLO) by
  80.0% during the 4th quarter, according to the company in its most recent Form 13F
  filing with the SEC. The fund owned 26,026 shares of the companys stock after selling
  104,125 shares during the quarter. ...


Citigroup Inc. Cuts Holdings in Diplomat Pharmacy Inc (NYSE:DPLO)

---
- Bank of Montreal Can trimmed its position in Diplomat Pharmacy Inc (NYSE:DPLO) by
  25.9% during the fourth quarter, according to the company in its most recent Form
  13F filing with the Securities and Exchange Commission. The institutional investor
  owned 8,204 shares of the companys stock after...


Bank of Montreal Can Lowers Stock Holdings in Diplomat Pharmacy Inc (NYSE:DPLO)

---
- Blueshift Asset Management LLC lifted its stake in shares of Diplomat Pharmacy Inc
  (NYSE:DPLO) by 22.0% in the 4th quarter, HoldingsChannel.com reports. The fund owned
  40,296 shares of the companys stock after acquiring an additional 7,280 shares during
  the quarter. Blueshift Asset Management...


Diplomat Pharmacy Inc (NYSE:DPLO) Stock Position Raised by Blueshift Asset Management LLC

---
- Shares of Diplomat Pharmacy Inc (NYSE:DPLO) have earned a consensus rating of Hold
  from the twelve analysts that are covering the firm, MarketBeat Ratings reports.
  Four analysts have rated the stock with a sell recommendation, seven have given
  a hold recommendation and one has assigned...


Diplomat Pharmacy Inc (NYSE:DPLO) Receives Average Recommendation of "Hold" from Brokerages

---
- Charles Schwab Investment Management Inc. boosted its position in shares of Diplomat
  Pharmacy Inc (NYSE:DPLO) by 27.1% in the fourth quarter, according to the company
  in its most recent 13F filing with the Securities and Exchange Commission (SEC).
  The fund owned 1,392,674 shares of the company&#8217...


Charles Schwab Investment Management Inc. Has $5.57 Million Stake in Diplomat Pharmacy Inc (NYSE:DPLO)

Diplomat is a nationally recognized specialty pharmacy, and here, we offer a special kind of care. At Diplomat, we blend clinical excellence with a personal touch, providing medications and support to people with serious long-term diseases, including cancer, multiple sclerosis, HIV and rheumatoid arthritis. Through our partnerships, we offer specialty care in retail pharmacies across the U.S. and grant specialty-care coverage to millions of lives nationwide.

Watchers	991
52-Wk Low	$0.00
52-Wk High	$0.00

Market Cap	$0.00
Volume (M)	744,968.00
52-Wk High	$0.00
52-Wk Low	$0.00

DPLO Diplomat Pharmacy

About

Feed

News

Fundamentals